GL1X · GenesisL1 explorer

MolNFT v1 · #88167 · protein

Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 2-((1R)-1-((3-amino-6-(2-methoxypyridin-3-YL)PYRAZIN-2-yl) OXY)ETHYL)-4-fluoro-N-methylbenzamide

4CMO · ALK tyrosine kinase receptor: “Structure of the human anaplastic lymphoma kinase in complex with the inhibitor…”. X-ray diffraction, 1 ligand (YPW), 2 pockets (best druggability 0.62). MolNFT v1 #88167 on GenesisL1: 3D structure…

PDB
4CMO
Type
protein
Length
295 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ALK tyrosine kinase receptor
EC
2.7.10.1
UniProt
Q9UM73
Ligands
YPW
Pockets
2 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AALK tyrosine kinase receptor (EC 2.7.10.1)protein29543% helix, 15% strandQ9UM73

Ligands and binding sites

  • YPW · 2-[(1R)-1-{[3-amino-6-(2-methoxypyridin-3-yl)pyrazin-2-yl]oxy}ethyl]-4-fluoro-N-methylbenzamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13670.620.7844YPW
2510.340.7915empty

Compared structures

  • 4CMO · Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UM73 · AlphaFold monomer V2.0 prediction for ALK tyrosine kinase receptor (Q9UM73) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.